openPR Logo
Press release

Pharmaveda revolutionizing the field of indigenous medicine

08-18-2021 03:24 PM CET | Health & Medicine

Press release from: India PR Distribution

Pharmaveda

Pharmaveda

India, 13th August 2021:- Pharmaveda is a company developing and manufacturing specialty ayurvedic medicines that have revolutionized the field of indigenous medicine from just hypothesis to proof in light of modern understanding of human physiology, biochemistry & pharmacological sciences. The Pharmaveda team consists of reputed scientists, researchers, doyens of the Indian Pharma Industry with huge experience, management experts, and administrative professionals. The company’s mission is to answer basic questions about ayurvedic medicines like what is their site and mode of action, in a language understood by modern sciences.
Ayurvedic medicines have been proved to improve longevity, enhance strength, and rejuvenate the body with very few incidences of side effects, due to their natural botanical & mineral origin. Pharmaveda has been very popular because of the way its products are developed. They blend the traditional knowledge and wisdom drawn over the centuries about Ayurveda, with modern research to combine them into products. The company follows safe manufacturing practices and has an in-house quality assurance lab with sophisticated analytical instruments under the leadership of Dr. Shefali Tungare, the Director of Quality Assurance.
Their product range has a variety of medicines like P-28, P2G, Psyllivac, Remaav, Detoxina, flo, Lomotral, Motabs, Capello etc. Team Pharmaveda has done pioneering work in immune-potentiation with ayurvedic medicines which lead to the development of the immune boosting medicine – Reimun. The clinical evaluation of Reimun as a stand-alone treatment modality in severely immunodeficient patients afflicted with HIV/AIDS & TB, has been conducted in various premier teaching medical intuitions of repute in India, and the data from these studies have been presented and accepted in major medical conferences across the globe.
Made with immunomodulatory ingredients like Katira, Chorak, Dudhal, Lalongo, giloy & ashwagandha, bhasma, etc., Reimun is a globally renowned immunity booster that has been approved by the FDA and has been in the market for 23 years without any reported sideeffects. The product (whose clinical trials showed that no patient displayed any adverse effects after even five years of follow-up) is produced in a cGMP, ISO 22000:2005, HACCP certified manufacturing facility, assuring the quality and safety of it.
The body of immune-boosting evidence in terms of robust clinical trials is what separates Reimun from claims by others. In fact, the Medicine Updates volumes of 2007, 2014 & 2019, published by the Association of Physicians of India, have also documented the role of Reimun as an immunomodulator in the treatment of tuberculosis including MDR-TB. Moreover, its use as an immunomodulator has also been endorsed by CCRAS, the nodal scientific body of the Government of India’s AYUSH Ministry.
In this era hit by the covid-19 pandemic, Reimun even helps strengthen immune defenses against the virus. Infection with SARS-CoV-2 practically depresses all the WBC subsets, especially all types of lymphocytes with a significant fall in the WBC numbers. Reimun revitalizes and stimulates the bone marrow-thymus axis to increase the generation of new immune cells to replace those that are dying.
Reimun provides several micronutrients such as iron, zinc, calcium, manganese, magnesium along with bioflavonoids, alkaloids, saponins, glycosides, etc. making it safe to be consumed by young and old alike (including geriatric or aged population). In short, Reimun revitalizes our immune system to make it alert and elicit a prompt & robust immune response against invading pathogens to keep people in good health.
Dr. Satish Vaidya, one of the founders of Pharmaveda said,“We have drawn huge inputs from my teachers who were internationally reputed scientists, pharmacologists, biochemists, and practitioners from both modern medical specialties& Ayurveda. Our vision behind creating Pharmaveda was to show the world the holistic approach of Ayurveda which is based on the concept of 3 humors or tridoshas – Vata, Pitta &Kapha – and the balance of it for good health can also be rationally explained in terms of modern-day pharmacology & biochemistry. I wanted to put the well-defined, remarkable, and distinct biological effects of ayurvedic & herbal drugs to good use in the service of our people.”
To learn more, visit:
Pharmaveda
www.ayushchakra.com

Ashokchakra
BS-​4, kamdar Shopping Centre,
Tejpal Road, Vile Parle (E),
Mumbai - 400057

AyushChakra was created to show the world the centuries old practice of Ayurveda through the eyes of Modern Science. The benefits of Ayurveda are known to every Indian.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmaveda revolutionizing the field of indigenous medicine here

News-ID: 2358659 • Views: 330

More Releases from India PR Distribution

Poet Prashant Bebaar’s debut book ‘Dareeche’ launched by music maestro Anu …
Dareeche, a collection of poems in Hindustani by Prashant 'Bebaar' gets launched by ghazal and bhajan samrat Anup Jalota Prashant Bebaar, a Hindi-Urdu poet who has been writing for almost two decades has now come up with his debut collection of poems ‘Dareeche’. This collection reached music maestro Anup Jalota in Mumbai and has gained popularity overnight. At a time when Hindi-Urdu literature is seeking revival, more than 1000 copies of
Nitin Jain, a Serial Entrepreneur, Launches New Influencer Marketing Packages
Nitin Jain, an award-winning serial entrepreneur in India, has launched one of India’s most economical influencer marketing services for both Indian and global companies looking to promote their product or services with the help of Instagram influencers. Gurgaon, Haryana, India., November 23, 2020 -- Nitin Jain, an award-winning serial entrepreneur in India, has launched one of India’s most economical influencer marketing services for both Indian and global companies looking to promote

More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business